SIMILAR EFFICACY AND SAFETY BETWEEN LENVATINIB VERSUS ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA

Chung-Wei Su; Wei Teng; Po-Ting Lin; Wen-Juei Jeng; Kuei-An Chen; Yi-Chung Hsieh; Wei-Ting Chen; Ming-Mo Hou; Chia-Hsun Hsieh; Chen-Chun Lin; Chun-Yen Lin; Hsi-Ming Lin

SIMILAR EFFICACY AND SAFETY BETWEEN LENVATINIB VERSUS ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA

Chung-Wei Su, Wei Teng, Po-Ting Lin, Wen-Juei Jeng, Kuei-An Chen, Yi-Chung Hsieh, Wei-Ting Chen, Ming-Mo Hou, Chia-Hsun Hsieh, Chen-Chun Lin, Chun-Yen Lin, Hsi-Ming Lin

醫學系

研究成果: 期刊稿件 › 文章 › 同行評審

原文	美式英語
期刊	Hepatology
卷	76
出版狀態	已出版 - 2022

引用此

@article{91c3238657ec43718b6ee583b9154734,

title = "SIMILAR EFFICACY AND SAFETY BETWEEN LENVATINIB VERSUS ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA",

author = "Chung-Wei Su and Wei Teng and Po-Ting Lin and Wen-Juei Jeng and Kuei-An Chen and Yi-Chung Hsieh and Wei-Ting Chen and Ming-Mo Hou and Chia-Hsun Hsieh and Chen-Chun Lin and Chun-Yen Lin and Hsi-Ming Lin",

year = "2022",

language = "American English",

volume = "76",

journal = "Hepatology",

issn = "0270-9139",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - SIMILAR EFFICACY AND SAFETY BETWEEN LENVATINIB VERSUS ATEZOLIZUMAB PLUS BEVACIZUMAB FOR UNRESECTABLE HEPATOCELLULAR CARCINOMA

AU - Su, Chung-Wei

AU - Teng, Wei

AU - Lin, Po-Ting

AU - Jeng, Wen-Juei

AU - Chen, Kuei-An

AU - Hsieh, Yi-Chung

AU - Chen, Wei-Ting

AU - Hou, Ming-Mo

AU - Hsieh, Chia-Hsun

AU - Lin, Chen-Chun

AU - Lin, Chun-Yen

AU - Lin, Hsi-Ming

PY - 2022

Y1 - 2022

M3 - Journal Article

SN - 0270-9139

VL - 76

JO - Hepatology

JF - Hepatology

ER -